Lothar Schweigerer

11.6k total citations · 5 hit papers
87 papers, 9.5k citations indexed

About

Lothar Schweigerer is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Lothar Schweigerer has authored 87 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 29 papers in Neurology and 25 papers in Cancer Research. Recurrent topics in Lothar Schweigerer's work include Neuroblastoma Research and Treatments (27 papers), Cancer, Hypoxia, and Metabolism (22 papers) and Fibroblast Growth Factor Research (13 papers). Lothar Schweigerer is often cited by papers focused on Neuroblastoma Research and Treatments (27 papers), Cancer, Hypoxia, and Metabolism (22 papers) and Fibroblast Growth Factor Research (13 papers). Lothar Schweigerer collaborates with scholars based in Germany, United States and Greece. Lothar Schweigerer's co-authors include Denis Gospodarowicz, Gera Neufeld, Napoleone Ferrara, Roberto Montesano, Michael S. Pepper, Herman Adlercreutz, Theodore Fotsis, Matthias Wilm, Tony Houthaeve and Matthias Mann and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Lothar Schweigerer

86 papers receiving 9.1k citations

Hit Papers

Femtomole sequencing of proteins from polyacrylamide gels... 1987 2026 2000 2013 1996 1987 1987 1994 1993 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry
    1996 1.4k citations Lothar Schweigerer, Theodore Fotsis et al. profile →
  2. Structural Characterization and Biological Functions of Fibroblast Growth Factor
    1987 1.1k citations Denis Gospodarowicz, Napoleone Ferrara et al. profile →
  3. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth
    1987 655 citations Lothar Schweigerer, Gera Neufeld et al. profile →
  4. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth
    1994 638 citations Michael S. Pepper, Herman Adlercreutz et al. profile →
  5. Genistein, a dietary-derived inhibitor of in vitro angiogenesis.
    1993 607 citations T. Fotsis, Michael S. Pepper et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lothar Schweigerer Germany 43 5.5k 1.5k 1.4k 1.2k 1.2k 87 9.5k
Christer Wernstedt Sweden 45 6.1k 1.1× 829 0.6× 1.5k 1.1× 995 0.8× 919 0.8× 85 9.5k
Russell M. Lebovitz United States 26 9.9k 1.8× 1.9k 1.3× 1.8k 1.3× 699 0.6× 2.1k 1.7× 49 14.9k
Hermann-Josef Gröne Germany 62 5.0k 0.9× 942 0.6× 1.3k 1.0× 938 0.8× 878 0.7× 170 11.9k
O. Wesley McBride United States 57 7.3k 1.3× 1.1k 0.8× 2.2k 1.6× 999 0.8× 1.6k 1.3× 131 12.2k
Michael J. Weber United States 66 12.7k 2.3× 2.0k 1.4× 3.5k 2.5× 2.3k 1.9× 1.6k 1.3× 196 17.4k
Angela Bachi Italy 56 7.4k 1.3× 983 0.7× 1.1k 0.8× 1.1k 0.9× 732 0.6× 200 11.2k
Orian S. Shirihai United States 63 11.2k 2.0× 1.7k 1.1× 954 0.7× 1.5k 1.2× 692 0.6× 163 16.8k
Leonard D. Kohn United States 63 6.2k 1.1× 697 0.5× 1.1k 0.8× 831 0.7× 2.0k 1.7× 324 13.9k
Anton Wellstein United States 52 6.1k 1.1× 1.6k 1.1× 2.1k 1.5× 2.1k 1.7× 1.2k 1.0× 223 9.4k
Matthias P. Wymann Switzerland 58 9.0k 1.6× 921 0.6× 1.9k 1.4× 1.7k 1.4× 589 0.5× 138 14.6k

Countries citing papers authored by Lothar Schweigerer

Since Specialization
Citations

This map shows the geographic impact of Lothar Schweigerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lothar Schweigerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lothar Schweigerer more than expected).

Fields of papers citing papers by Lothar Schweigerer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lothar Schweigerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lothar Schweigerer. The network helps show where Lothar Schweigerer may publish in the future.

Co-authorship network of co-authors of Lothar Schweigerer

This figure shows the co-authorship network connecting the top 25 collaborators of Lothar Schweigerer. A scholar is included among the top collaborators of Lothar Schweigerer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lothar Schweigerer. Lothar Schweigerer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Decarolis, Boris, Thorsten Simon, Barbara Krug, et al.. (2016). Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixed. BMC Cancer. 16(1). 542–542. 82 indexed citations
2.
Volland, Sonja, Wilfried Kugler, Lothar Schweigerer, Jörg Wilting, & Jürgen Becker. (2009). Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma. International Journal of Cancer. 125(9). 2049–2057. 46 indexed citations
3.
Papoutsi, Maria, et al.. (2007). Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas. BMC Cancer. 7(1). 105–105. 43 indexed citations
4.
Wilting, Jörg, Kerstin Buttler, Jochen Rößler, et al.. (2007). Embryonic Development and Malformation of Lymphatic Vessels. Novartis Foundation symposium. 283. 220–229. 9 indexed citations
5.
Milde, Till, Leonor Alamo, Christine Stadelmann, Lothar Schweigerer, & Olaf Witt. (2005). Multifocal Osteochondroma After Repeated Irradiation in a Boy With Hodgkin Disease. Journal of Pediatric Hematology/Oncology. 27(6). 344–345. 3 indexed citations
6.
Wilting, Jörg, Stanislav I. Tomarev, Bodo Christ, & Lothar Schweigerer. (2003). Lymphangioblasts in Embryonic Lymphangiogenesis. Lymphatic Research and Biology. 1(1). 33–40. 14 indexed citations
7.
Zebger‐Gong, Hong, Christoph Pöttgen, Georg Stüben, et al.. (2003). Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: Potentiation by irradiation. International Journal of Cancer. 106(5). 723–728. 38 indexed citations
8.
Breit, Stephen, Jochen Rößler, Theodore Fotsis, & Lothar Schweigerer. (2000). N-myc Down-Regulates Activin A. Biochemical and Biophysical Research Communications. 274(2). 405–409. 6 indexed citations
9.
Schweigerer, Lothar. (1997). Clinical Perspectives of Tumor Angiogenesis in Pediatric Oncology. Klinische Pädiatrie. 209(4). 257–264. 1 indexed citations
10.
Schweigerer, Lothar, et al.. (1995). Why is ascorbate toxic to neuroblastoma cell lines and why does this toxicity increase with cell line malignancy?. Redox Report. 1(3). 225–227. 3 indexed citations
11.
Fotsis, T., Michael S. Pepper, Herman Adlercreutz, et al.. (1995). Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis.. PubMed. 125(3 Suppl). 790S–797S. 237 indexed citations
12.
Pepper, Michael S., J D Vassalli, Lelio Orci, et al.. (1994). Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis. Journal of Cellular Biochemistry. 55(4). 419–434. 71 indexed citations
13.
Schweigerer, Lothar, Herman Adlercreutz, Kristiina Wähälä, et al.. (1992). Identification in human urine of a natural growth inhibitor for cells derived from solid paediatric tumours. European Journal of Clinical Investigation. 22(4). 260–264. 56 indexed citations
14.
Schweigerer, Lothar, et al.. (1991). Enhanced MYCN oncogene expression in human neuroblastoma cells is associated with altered FGF receptor expression and cellular growth response to basic FGF. Biochemical and Biophysical Research Communications. 179(3). 1449–1454. 10 indexed citations
15.
Schweigerer, Lothar & T. Fotsis. (1991). Erhöhte Expression des MYCN Onkogens in humanen Neuroblastomzellen und mögliche, neue Therapie-Ansätze. Klinische Pädiatrie. 203(4). 319–322. 1 indexed citations
16.
Schweigerer, Lothar. (1989). Fibroblast growth factor and angiogenesis.. PubMed. 78 Suppl 6. 12–5. 17 indexed citations
17.
Schweigerer, Lothar, et al.. (1988). Basic fibroblast growth factor: Expression in cultured cells derived from corneal endothelium and lens epithelium. Experimental Eye Research. 46(1). 71–80. 70 indexed citations
18.
Schweigerer, Lothar. (1988). Basic fibroblast growth factor and its relation to angiogenesis in normal and neoplastic tissue. Journal of Molecular Medicine. 66(8). 340–345. 13 indexed citations
19.
Schweigerer, Lothar, Gera Neufeld, Jeff Friedman, et al.. (1987). Basic Fibroblast Growth Factor: Production and Growth Stimulation in Cultured Adrenal Cortex Cells*. Endocrinology. 120(2). 796–800. 58 indexed citations
20.
Schweigerer, Lothar, Hansjörg Teschemacher, & Sucharit Bhakdi. (1982). Interaction of human β-endorphin with the terminal SC5b-9 and “preterminal” SC5b-7 and SC5b-8 complexes of human complement. Life Sciences. 31(20-21). 2275–2278. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christer Wernstedt Breakdown of academic impact, for papers by Russell M. Lebovitz Breakdown of academic impact, for papers by Hermann-Josef Gröne Breakdown of academic impact, for papers by O. Wesley McBride Breakdown of academic impact, for papers by Michael J. Weber Breakdown of academic impact, for papers by Angela Bachi Breakdown of academic impact, for papers by Orian S. Shirihai Breakdown of academic impact, for papers by Leonard D. Kohn Breakdown of academic impact, for papers by Anton Wellstein Breakdown of academic impact, for papers by Matthias P. Wymann
Rankless by CCL
2026